Are People Holding Their Arms Incorrectly for Blood Pressure Tests?
By Carole Tanzer Miller HealthDay Reporter
MONDAY, Oct. 7, 2024 -- Checking your blood pressure at home? Pay attention to arm position.
A new study by Johns Hopkins researchers confirms that it makes a "huge difference" when it comes to getting an accurate measurement. And, the authors add, health care providers need to be more careful about it, too.
"[Patients] must advocate for themselves in the clinical setting and when measuring their BP at home," said senior study author Dr. Tammy Brady, vice chair for clinical research in the department of pediatrics at Johns Hopkins University School of Medicine.
Nearly half of U.S. adults have elevated blood pressure, according to the American Heart Association (AHA).
The diagnosis is made when the force of blood flowing through blood vessels is higher than normal (120/80, on average). Left untreated, hypertension puts a person at increased risk of stroke, heart attack and other serious heart conditions.
The new study looked at the effects of three arm positions during a blood pressure test: supported on a desk; supported on a lap; and hanging at the patient's side.
The study found that lap support overestimated systolic blood pressure (the top number in a blood pressure reading) by nearly 4 mmHg, while an arm hanging at the patients side overestimated it by nearly 7 mmHg.
Systolic pressure is the pressure against artery walls when the heart beats.
AHA guidelines for measuring blood pressure call for an appropriately sized cuff; back support; feet flat on the floor with legs uncrossed; and appropriate arm position.
What is that correct arm position? According to the AHA, the blood pressure cuff should be positioned at mid-heart level on an arm that is supported on a desk or table.
But researchers found that clinicians often measure blood pressure while patients are seated on an exam table with little, if any, arm support.
For the study, they recruited 133 adults from age 18 to 80. Participants were randomly assigned to one of six groups that differed by order of three seated arm positions. Before their blood pressure was taken, they emptied their bladder and walked for two minutes, then had a five-minute seated rest period with backs and feet supported.
Each had three measurements with the three seated positions. Between each set, they walked for two minutes and rested for five. They also had a fourth set of measurements with their arm supported on a desk.
Researchers found that measurements obtained with an arm on the lap or unsupported at the side were markedly higher than those obtained with the arm supported on a desk as recommended.
Supporting the arm on the lap overestimated pressure by 3.9/4.0. Unsupported arm at the side overestimated pressure by 6.5/4.4.
"If you are consistently measuring blood pressure with an unsupported arm, and that gives you an overestimated BP of 6.5 mmHg, that's a potential difference between a systolic BP of 123 and 130, or 133 and 140 -- which is considered stage 2 hypertension," said study author Sherry Liu, an epidemiology research coordinator at Johns Hopkins Bloomberg School of Public Health in Baltimore.
Her team noted that its results may only apply during screenings with automated blood pressure devices and not to those with other devices.
Nonetheless, Brady said in a Hopkins news release, the findings suggest that clinicians need to pay better attention to best practice guidelines.
The findings were published Oct. 7 in the journal JAMA Internal Medicine.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-10-08 06:00
Read more
- Endoscopic Full-Thickness Plication Efficacious for GERD
- U.S. Abortion Numbers Dipped Slightly in 2022
- Two Common Antiseizure Medications Do Not Harm Child Neurodevelopment
- Allergies Have You Stuffed Up? Nose Fungi May Be to Blame
- FDA Grants Revascor (Rexlemestrocel-L) Regenerative Medicine Advanced Therapy (RMAT) Designation in Children with Congenital Heart Disease
- FDA Approves Simplified Dosing Regimen for Acetadote (N-acetylcysteine for injection)
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions